Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

284 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
Farkouh ME, Greenberg BP. Farkouh ME, et al. Am J Cardiol. 2009 May 1;103(9):1227-37. doi: 10.1016/j.amjcard.2009.01.014. Am J Cardiol. 2009. PMID: 19406264 Review.
The vulnerable plaque and acute coronary syndromes.
Corti R, Farkouh ME, Badimon JJ. Corti R, et al. Among authors: farkouh me. Am J Med. 2002 Dec 1;113(8):668-80. doi: 10.1016/s0002-9343(02)01344-x. Am J Med. 2002. PMID: 12505118 Review.
Association between troponin I levels and mortality in stable hemodialysis patients.
Farkouh ME, Robbins MJ, Zafar MU, Shimbo D, Davidson KW, Puttappa R, Winston J, Halperin JL, Epstein EM, Patel M, Talor Z, Chesebro JH. Farkouh ME, et al. Am J Med. 2003 Feb 15;114(3):224-6. doi: 10.1016/s0002-9343(02)01482-1. Am J Med. 2003. PMID: 12637137 No abstract available.
Relation between the degree of procedural anticoagulation and complications after coronary stent implantation.
Ashby DT, Dangas G, Aymong EA, Farkouh ME, Mehran R, Lansky AJ, Moses JW, Leon MB, Stone GW. Ashby DT, et al. Among authors: farkouh me. Am J Cardiol. 2003 Aug 1;92(3):319-22. doi: 10.1016/s0002-9149(03)00637-4. Am J Cardiol. 2003. PMID: 12888144 Clinical Trial.
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.
Farkouh ME, Kirshner H, Harrington RA, Ruland S, Verheugt FW, Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Gimona A, Matchaba P, Hawkey CJ, Chesebro JH; TARGET Study Group. Farkouh ME, et al. Lancet. 2004 Aug 21-27;364(9435):675-84. doi: 10.1016/S0140-6736(04)16894-3. Lancet. 2004. PMID: 15325832 Clinical Trial.
The incremental value of troponin-I testing in patients with intermediate risk unstable angina.
Appelbaum E, Zafar MU, Glick HC, Stec S, Southern W, Sarkozi L, Wallenstein S, Chesebro JH, Farkouh ME. Appelbaum E, et al. Among authors: farkouh me. Clin Cardiol. 2004 Nov;27(11):646-51. doi: 10.1002/clc.4960271113. Clin Cardiol. 2004. PMID: 15562936 Free PMC article.
Cardiovascular disease in diabetics: pharmacology and revascularization.
Mangalmurti SS, Farkouh ME. Mangalmurti SS, et al. Among authors: farkouh me. Mt Sinai J Med. 2004 Nov;71(6):375-83. Mt Sinai J Med. 2004. PMID: 15592656 Review.
COX-2 inhibitors and hypercoagulability.
Farkouh ME. Farkouh ME. Clin Adv Hematol Oncol. 2005 Jan;3(1):35-6. Clin Adv Hematol Oncol. 2005. PMID: 16166966 No abstract available.
Elevated homocysteine levels in patients with end-stage renal disease.
Nair AP, Nemirovsky D, Kim M, Geer EB, Farkouh ME, Winston J, Halperin JL, Robbins MJ. Nair AP, et al. Among authors: farkouh me. Mt Sinai J Med. 2005 Nov;72(6):365-73. Mt Sinai J Med. 2005. PMID: 16358160
Cardiovascular effects of selective COX-2 inhibition: is there a class effect? The International COX-2 Study Group.
Crofford LJ, Breyer MD, Strand CV, Rushitzka F, Brune K, Farkouh ME, Simon LS. Crofford LJ, et al. Among authors: farkouh me. J Rheumatol. 2006 Jul;33(7):1403-8. Epub 2006 May 15. J Rheumatol. 2006. PMID: 16724374
284 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page